The Lancet Commission on prostate cancer: planning for the surge in cases (2024)
Attributed to:
Evaluating new healthcare technologies in cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(24)00651-2
Publication URI: http://dx.doi.org/10.1016/s0140-6736(24)00651-2
Type: Journal Article/Review
Parent Publication: The Lancet